NCT00430950 - Combination of Olmesartan and Hydrochlorothiazide in Essential Hypertension | Biotech Hunter

Enrollment

1,011

Participants

Timeline

Start Date

February 28, 2007

Primary Completion Date

May 31, 2008

Study Completion Date

October 31, 2008

Conditions

Essential Hypertension

Interventions

DRUG

olmesartan medoxomil (OM)+ hydrochlorothiazide (HCTZ) tablets

olmesartan medoxomil (OM)+ hydrochlorothiazide (HCTZ)tablets 40mg/25mg + 20mg/25mg matching placebo tablets once daily for 8 weeks

DRUG

olmesartan medoxomil (OM)/ hydrochlorothiazide (HCTZ) 20mg/25mg

olmesartan medoxomil (OM)/hydrochlorothiazide (HCTZ)20mg/25mg tablet + 40mg/25mg matching placebo tablet once a day for 8 weeks

Trial Locations (41)

Unknown

Bruges

Brussels

Drongen

Godinne

Mouscron

Wetteren

Berlin

Dortmund

Essen

Frankfurt

Goch

Hamburg

Kallstadt

Karlsruhe

Kassel

Magdeburg

Marburg

München

Wiesbaden

Wuppertal

's-Hertogenbosch

Alphen aan den Rijn

Amsterdam-Zuidoost

Andijk

De Bilt

Ewijk

Heerlen

Hengelo

Landgraaf

Nijmegen

Oud-Beijerland

Ridderkerk

The Hague

Wildervank

Zwijndrecht

Bratislava

Levice

Lučenec

Nitra

Nové Zámky

Vráble